Advertisement

Topics

Compugen Ltd. Company Profile

00:49 EDT 26th September 2018 | BioPortfolio

Compugen is a leading drug and diagnostic product candidate discovery company. Unlike traditional high throughput trial and error experimental based discovery, Compugen's discovery efforts are based on in silico (by computer) prediction and selection utilizing a growing number of field focused proprietary discovery platforms accurately modeling biological processes at the molecular level. Compugen's growing number of collaborations with major pharmaceutical and diagnostic companies cover both (i) the licensing of product candidates discovered by Compugen during the validation of its discovery platforms and in its internal research, and (ii) 'discovery on demand' agreements where existing or new Compugen discovery platforms are utilized to predict and select product candidates as required by a partner. In 2002, Compugen established an affiliate, Evogene Ltd. (www.evogene.com) (TASE: EVGN), to utilize certain of the Company's 'in silica' predictive discovery capabilities in agricultural biotechnology. For additional information, please visit Compugen's corporate website at: www.cgen.com.


News Articles [40 Associated News Articles listed on BioPortfolio]

MedImmune to Develop Compugen Immuno-Oncology Antibodies

AstraZeneca’s MedImmune subsidiary has agreed to exclusively license and develop bi-specific and multi-specific immuno-oncology antibody products from Compugen’s pipeline, through a collaboration ...

Compugen inks I-O deal worth over $210 million with AZ unit

Compugen has entered into an exclusive license agreement with MedImmune.

Compugen earns $7.8m payment from Bayer

The continued development of cancer drug BAY 1905254 is a major boost for Compugen's ability to successfully identify new mechanisms for treatments using its big data systems.

AZ signs up for access to Compugen’s pipeline

AstraZeneca’s MedImmune has inked a deal with Israeli group Compugen giving it access to the firm’s experimental bi- and multi-specific antibody products.

Compugen’s Powers of Prediction

Do we really have a good understanding of how life works at a molecular level? Martin Gerstel, Chairman of Compugen, explains how the company has created a computer that can accurately model the behav...

Compugen doses first patient in Phase l trial of COM701

Compugen has dosed the first patient in a Phase l clinical trial of COM701 for the treatment of patients with...Read More... The post Compugen doses first patient in Phase l trial of COM701 appeared f...

Compugen and MedImmune enter exclusive license agreement

MedImmune LLC and Compugen Ltd. penned an agreement for the development of bispecific and multi-specific antibody therapies for cancer.

Registered direct offering nets $20mm for Compugen

Compugen Ltd. netted $20mm through a registered direct offering of 5.3mm ordinary shares at $3.95 (a 4% premium). Investors also received five-year warrants to purchase 4.3mm shares at $4.74. JMP Secu...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [5 Associated Companies listed on BioPortfolio]

Compugen Ltd.

Compugen is a leading drug and diagnostic product candidate discovery company. Unlike traditional high throughput trial and error experimental based discovery, Compugen's discovery efforts are b...

Compugen

Compugen is a leading drug and diagnostic product candidate discovery company. Unlike traditional high throughput trial and error experimental based discovery, Compugen’s discovery efforts are based...

Compugen Ltd. Compugen Ltd.

Compugen is a leading therapeutic product discovery company focused on therapeutic proteins and monoclonal antibodies to address important unmet needs in the fields of immunology ...

Neviah Genomics

Neviah Genomics was jointly established in 2012 by Merck Serono, the biopharmaceutical business of Merck, and Compugen Ltd. The company operates out of the MS Ventures’ Israe...

BioLineRx Ltd. and Compugen Ltd.

BioLineRx Ltd. is a publicly-traded biopharmaceutical development company. It is dedicated to building a portfolio of products for unmet medical needs or with advantages over curr...

More Information about "Compugen Ltd." on BioPortfolio

We have published hundreds of Compugen Ltd. news stories on BioPortfolio along with dozens of Compugen Ltd. Clinical Trials and PubMed Articles about Compugen Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Compugen Ltd. Companies in our database. You can also find out about relevant Compugen Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...


Corporate Database Quicklinks



Searches Linking to this Company Record